Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 820

Results For "AI"

8753 News Found

HUL funds study on Covid-19 vulnerability and vaccine efficiency
News | September 07, 2021

HUL funds study on Covid-19 vulnerability and vaccine efficiency

The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.


Anti-dumping duty proposed on Vitamin C from China for five years
News | September 07, 2021

Anti-dumping duty proposed on Vitamin C from China for five years

The DGTR has recommended US $ 3.2 per kg and US $ 3.55 per kg duty on imports


Zydus Cadila’s Sitagliptin base tablets receive tentative approval from US FDA
Drug Approval | September 06, 2021

Zydus Cadila’s Sitagliptin base tablets receive tentative approval from US FDA

Zydus’ Sitagliptin base contains the active moiety Sitagliptin in a different form than used in the branded reference product, Januvia (Sitagliptin Phosphate)


DGCI approves Hetero’s Tocilizumab
Drug Approval | September 06, 2021

DGCI approves Hetero’s Tocilizumab

Hetero’s drug is a biosimilar version of Roche’s Actemra/RoActemra and will be available at the end of this month


Brinton launches Hohner Health in India
Healthcare | September 06, 2021

Brinton launches Hohner Health in India

The focus is on wellness and personal care products


Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19
Drug Approval | September 06, 2021

Bajaj Healthcare gets a go-ahead for 2-Deoxy-D-Glucose to treat Covid-19

Marketed under the brand name DGJAJ, it helps in the faster recovery of hospitalised patients and reduces supplemental oxygen dependence


TB Alliance partners with Lupin for non-exclusive anti-TB drug
Policy | September 06, 2021

TB Alliance partners with Lupin for non-exclusive anti-TB drug

According to WHO, over 1.5 million people died of TB in 2020


CRAMS to drive growth for Indian pharma industry: report
News | September 06, 2021

CRAMS to drive growth for Indian pharma industry: report

The global CRAMS segment is expected to clock 6.2% CAGR over CY21-26E to touch US $ 170 billion


Accutest enables NMPA approval for Qilu’s Abiraterone
Drug Approval | September 06, 2021

Accutest enables NMPA approval for Qilu’s Abiraterone

The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India


NF Healthcare launch latest version of its oxygen generators
Healthcare | September 06, 2021

NF Healthcare launch latest version of its oxygen generators

The newest entrant from the company is the MOSS 1800F with an oxygen flow rate of 180 LPM or 10.8 Nm3/hour